Literature DB >> 11607816

Modeling Philadelphia chromosome positive leukemias.

S Wong1, O N Witte.   

Abstract

The Ph chromosome has been genetically linked to CML and ALL. Its chimeric fusion gene product, BCR-ABL, can generate leukemia in mice. This review will discuss selected model systems developed to study BCR-ABL induced leukemia and focuses on what we have learned about the human disease from these models. Five main experimental approaches will be discussed including: (i) Reconstitution of mice with bone marrow cells retrovirally transduced with BCR-ABL; (ii) Transgenic mice expressing BCR-ABL; (iii) Knock-in mice with BCR-ABL expression driven from the endogenous bcr locus; (iv) Development of CML-like disease in mice with loss of function mutations in heterologous genes; and (v) ES in vitro hematopoietic differentiation coupled with regulated BCR-ABL expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11607816     DOI: 10.1038/sj.onc.1204638

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia.

Authors:  Robert A J Signer; Encarnacion Montecino-Rodriguez; Owen N Witte; Jami McLaughlin; Kenneth Dorshkind
Journal:  Blood       Date:  2007-06-06       Impact factor: 22.113

Review 2.  Targeted therapy of chronic myeloid leukemia.

Authors:  Con Sullivan; Cong Peng; Yaoyu Chen; Dongguang Li; Shaoguang Li
Journal:  Biochem Pharmacol       Date:  2010-05-12       Impact factor: 5.858

Review 3.  Mechanisms determining the fate of hematopoietic stem cells.

Authors:  Shouheng Lin; Ruocong Zhao; Yiren Xiao; Peng Li
Journal:  Stem Cell Investig       Date:  2015-05-15

4.  Mouse models as tools to understand and study BCR-ABL1 diseases.

Authors:  Steffen Koschmieder; Mirle Schemionek
Journal:  Am J Blood Res       Date:  2011-06-07

5.  Increased sensitivity of BCR-ABL-induced B-ALL to imatinib by releasing leukemia B cell differentiation blockage.

Authors:  Zi Wang; Yong Li; Xiaokai Lu; Jia Yuan; Qiang Qiu; Cong Pan
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

6.  Expression of BCR/ABL p210 from a knockin allele enhances bone marrow engraftment without inducing neoplasia.

Authors:  Samantha B Foley; Zacariah L Hildenbrand; Abigail A Soyombo; Jeffery A Magee; Yipin Wu; Katherine I Oravecz-Wilson; Theodora S Ross
Journal:  Cell Rep       Date:  2013-10-03       Impact factor: 9.423

Review 7.  Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD).

Authors:  Toshio Kitamura; Naoko Watanabe-Okochi; Yutaka Enomoto; Fumio Nakahara; Toshihiko Oki; Yukiko Komeno; Naoko Kato; Noriko Doki; Tomoyuki Uchida; Yuki Kagiyama; Katsuhiro Togami; Kimihito C Kawabata; Koutarou Nishimura; Yasutaka Hayashi; Reina Nagase; Makoto Saika; Tsuyoshi Fukushima; Shuhei Asada; Takeshi Fujino; Yuto Izawa; Sayuri Horikawa; Tomofusa Fukuyama; Yosuke Tanaka; Ryoichi Ono; Susumu Goyama; Tetsuya Nosaka; Jiro Kitaura; Daichi Inoue
Journal:  J Biochem       Date:  2015-11-20       Impact factor: 3.387

Review 8.  Bcr-Abl is a "molecular switch" for the decision for growth and differentiation in hematopoietic stem cells.

Authors:  Takumi Era
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

9.  Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics.

Authors:  Jami McLaughlin; Donghui Cheng; Oded Singer; Rita U Lukacs; Caius G Radu; Inder M Verma; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-13       Impact factor: 11.205

10.  CCN3: a key growth regulator in Chronic Myeloid Leukaemia.

Authors:  Lynn McCallum; Wanhua Lu; Susan Price; Noureddine Lazar; Bernard Perbal; Alexandra E Irvine
Journal:  J Cell Commun Signal       Date:  2009-07-22       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.